» Articles » PMID: 24363043

Non-raft Adenylyl Cyclase 2 Defines a CAMP Signaling Compartment That Selectively Regulates IL-6 Expression in Airway Smooth Muscle Cells: Differential Regulation of Gene Expression by AC Isoforms

Overview
Specialty Pharmacology
Date 2013 Dec 24
PMID 24363043
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Adenylyl cyclase (AC) isoforms differ in their tissue distribution, cellular localization, regulation, and protein interactions. Most cell types express multiple AC isoforms. We hypothesized that cAMP produced by different AC isoforms regulates unique cellular responses in human bronchial smooth muscle cells (BSMC). Overexpression of AC2, AC3, or AC6 had distinct effects on forskolin (Fsk)-induced expression of a number of known cAMP-responsive genes. These data show that different AC isoforms can differentially regulate gene expression. Most notable, overexpression and activation of AC2 enhanced interleukin 6 (IL-6) expression, but overexpression of AC3 or AC6 had no effect. IL-6 production by BSMC was induced by Fsk and select G protein-coupled receptor (GPCR) agonists, though IL-6 levels did not directly correlate with global cAMP levels. Treatment with PKA selective 6-Bnz-cAMP or Epac selective 8-CPT-2Me-cAMP cAMP analogs revealed a predominant role for PKA in cAMP-mediated induction of IL-6. IL-6 promoter mutations demonstrated that AP-1 and CRE transcription sites were required for Fsk to stimulate IL-6 expression. Our present study defines an AC2 cAMP signaling compartment that specifically regulates IL-6 expression in BSMC via Epac and PKA and demonstrates that other AC isoforms are excluded from this pool.

Citing Articles

Proteome and ubiquitinome analyses of the brain cortex in K18- mice infected with SARS-CoV-2.

Wang Q, Peng W, Yang Y, Wu Y, Han R, Ding T iScience. 2024; 27(9):110602.

PMID: 39211577 PMC: 11357812. DOI: 10.1016/j.isci.2024.110602.


Role of protein kinase A and A kinase anchoring proteins in buffering and compartmentation of cAMP signalling in human airway smooth muscle cells.

Sherpa R, Moshal K, Agarwal S, Ostrom R, Harvey R Br J Pharmacol. 2024; 181(15):2622-2635.

PMID: 38613158 PMC: 11219259. DOI: 10.1111/bph.16357.


Real-Time cAMP Dynamics in Live Cells Using the Fluorescent cAMP Difference Detector In Situ.

Cattani-Cavalieri I, Margolis J, Anicolaesei C, Nunez F, Ostrom R J Vis Exp. 2024; (205).

PMID: 38587373 PMC: 11149918. DOI: 10.3791/66451.


Quantitative phosphoproteomic analysis reveals unique cAMP signaling pools emanating from AC2 and AC6 in human airway smooth muscle cells.

Cattani-Cavalieri I, Li Y, Margolis J, Bogard A, Roosan M, Ostrom R Front Physiol. 2023; 14:1149063.

PMID: 36926196 PMC: 10011497. DOI: 10.3389/fphys.2023.1149063.


Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy.

Guo R, Liu T, Shasaltaneh M, Wang X, Imani S, Wen Q Front Oncol. 2022; 12:829212.

PMID: 35832555 PMC: 9271773. DOI: 10.3389/fonc.2022.829212.


References
1.
Willoughby D, Wong W, Schaack J, Scott J, Cooper D . An anchored PKA and PDE4 complex regulates subplasmalemmal cAMP dynamics. EMBO J. 2006; 25(10):2051-61. PMC: 1462982. DOI: 10.1038/sj.emboj.7601113. View

2.
Bogard A, Adris P, Ostrom R . Adenylyl cyclase 2 selectively couples to E prostanoid type 2 receptors, whereas adenylyl cyclase 3 is not receptor-regulated in airway smooth muscle. J Pharmacol Exp Ther. 2012; 342(2):586-95. PMC: 3400804. DOI: 10.1124/jpet.112.193425. View

3.
Jacobowitz O, Chen J, Premont R, Iyengar R . Stimulation of specific types of Gs-stimulated adenylyl cyclases by phorbol ester treatment. J Biol Chem. 1993; 268(6):3829-32. View

4.
Piggott L, Bauman A, Scott J, Dessauer C . The A-kinase anchoring protein Yotiao binds and regulates adenylyl cyclase in brain. Proc Natl Acad Sci U S A. 2008; 105(37):13835-40. PMC: 2544540. DOI: 10.1073/pnas.0712100105. View

5.
Bayewitch M, Avidor-Reiss T, Levy R, Pfeuffer T, Nevo I, Simonds W . Inhibition of adenylyl cyclase isoforms V and VI by various Gbetagamma subunits. FASEB J. 1998; 12(11):1019-25. DOI: 10.1096/fasebj.12.11.1019. View